Loss of SMARCA2 is an Adverse Prognostic Finding for Patients with Hepatocellular Carcinoma and Correlates with Early Disease Recurrence After Hepatectomy

LABORATORY INVESTIGATION(2022)

引用 0|浏览3
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要